Survey of the effect of the intravenous lidocaine during mastectomy on post operative pain and immune response.

Not Applicable

Recruiting

• Conditions: Postoperative pain and Immune response.; Other acute postprocedural pain; G89.18

• Registration Number: IRCT20121204011662N11
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

All patients who will be candidate for elective mastectomy due to breast tumor

Exclusion Criteria

Emergency patient;History of cardiac arrhythmia;Diabetes mellitus; Immune suppressive drugs; Corticosteriods;NSAIDs,; Renal and Liver failure; Hypersensetivity to lidocaine or contraindication of use of lidocaine.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of postoperative pain. Timepoint: Every 15 min in the recovery room, then 4, 8, 12,24 hr post operation in ward. Method of measurement: Visual analog Scale.;Immune system response. Timepoint: In the morning of operation and 24 hr post operation. Method of measurement: Interleukin 1 and 6 Kit.

Secondary Outcome Measures

Name	Time	Method
Patients satisfaction from pain control managment. Timepoint: 24 following operation. Method of measurement: Totally unsatisfactory=0, unsatisfactory=1,None=2,Satisfy=3, Completely satisfy=4.